PUBLICATIONS
연구개발 중심의 피플바이오는 꾸준하게 논문을 발표하고 있습니다.
PUBLICATIONS
-
2022Multimer Detection System-Oligomerized Amyloid Beta (MDS-OAβ): A Plasma-Based Biomarker Differentiates Alzheimer’s Disease from Other Etiologies of DementiaJacqueline Cotoong Dominguez , Jeryl Ritzi Tan Yu, Ma Fe De Guzman, Encarnita Ampil , Anne Cristine Guevarra, Ma. Lourdes Joson , Macario Reandelar, Ma. Socorro Martinez, Antonio Ligsay, Ferron Ocampo, and SangYun Kim
-
2021Stability of the novel blood-based biomarkers under pre-analytical sample handling conditions: Results of the SABB-GBSC working groupInge M.W. Verberk, Els O. Misdorp, Jannet Koelewijn, Andrew J. Ball, Kaj Blennow, Jeffrey L. Dage, Noelia Fandos, Oskar Hansson, Christophe Hirtz, Shorena Janelidze, Ryan Lee, Robert A. Rissman, Dandan Shan, Leslie M. Shaw, Kevin E. Yarasheski, Henrik Zetterberg, Rebecca M. Edelmayer, Charlotte E. Teunissen
-
2021Plasma amyloid-β oligomerization assay as a pre-screening test for amyloid statusRB. Mofrad, Philip Scheltens, Kim SY, Kang SM, Youn YC, An SSA, Jori Tomassen, Bart N. M. van Berckel, PJ.Visser, Wiesje M. van der Flier & Charlotte E. Teunissen
-
2021Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteinsKY. Kulichikhin, SA. Fedotov, MS. Rubel, NM. Zalutskaya, AE. Zobnina, OA. Malikova, NG. Neznanov, YO. Chernoff & AA. Rubel
-
2021Plasma Amyloid-β Oligomerization Tendency Predicts Amyloid PET PositivityPyun JM, Ryu JS, Lee R, Shim KH, Youn YC, Ryoo NY, Han SW, Park YH, Kang SM, An SSA, Kim SY
